Teleflex News (NYSE:TFX)

DateTimeSource
Headline
09/13/20176:45AMBWTeleflex to Present the Peripheral Intervention Product Portfolio from Its New Subsidiary, Vascular Solutions at the Annual M...
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, will showcase the product portfolio recently acquired from its new subsidiary, Vascular Solutions, as well as its Arrow® Hemodialysis, Oncology and Peripheral Intervention Solutions at the CIRSE... More...>>
09/11/20176:45AMBWTeleflex to Present at the 47th Annual Meeting of the International Continence Society (“ICS”)
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for Critical Care, Urology and Surgery, will showcase its advanced bladder management product lines at the 47th ICS (Annual Meeting of the International Continence Society) in Florence, Italy, on September 12-15, 2017. Teleflex offers one of... More...>>
09/05/20176:45AMBWTeleflex Incorporated to Acquire NeoTract
Significantly advances Teleflex’s offering of urological solutionsProvides differentiated, high-growth and high-margin product offering with demonstrable clinical benefitsCompelling financial profile expected to substantially enhance Teleflex’s revenue growth, margins, earnings and cash flow generation capabilities... More...>>
08/29/20176:45AMBWTeleflex to Present at the Morgan Stanley 15th Annual Global Healthcare Conference
Liam Kelly, President and COO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Morgan Stanley 15th Annual Global Healthcare Conference at the Grand Hyatt in New York City, Tuesday, September 12, 2017 at 2:55 p.m. (ET). A live audio webcast of the conference presentation, along with the accompanying slide... More...>>
08/23/20176:45AMBWTeleflex Awarded Group Purchasing Contract with Vizient Inc. for Non-Tunneled Central Venous Catheters
Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies for vascular access, has announced a new three year Product Category contract with Vizient Inc. for non-tunneled central venous catheters. Vizient is the largest member-driven health care performance improvement company in the country... More...>>
08/03/20176:45AMBWTeleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable September 15, 2017 to shareholders of record at the close of business on August 15, 2017. Additional information about Teleflex... More...>>
08/03/20176:30AMBWTeleflex Reports Second Quarter 2017 Results
Second Quarter Revenues of $528.6 million, up 11.6% Versus Prior Year Period; up 12.9% on Constant Currency Basis Second Quarter GAAP Diluted EPS of $1.67, up 33.6% Over Prior Year Period Second Quarter Adjusted Diluted EPS of $2.04, up 7.9% Versus Prior Year Period Raised 2017 Guidance Range for GAAP Revenue Growth from... More...>>
07/24/20176:45AMBWArrow® Seldinger Arterial Catheterization Device Receives FDA Market Clearance
Designed for Risk Reduction, Optimal Performance, and Patient Safety Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced today that its Arrow® Seldinger Arterial Catheterization Device received market clearance from the U.S. Food and Drug Administration... More...>>
07/20/20176:45AMBWTeleflex Announces Second Quarter 2017 Earnings Conference Call Information
Live Webcast is scheduled at 8:00 a.m. (ET) on Thursday, August 3, 2017 Teleflex Incorporated (NYSE: TFX) announced today that financial results for the second quarter 2017 will be released before market open on Thursday, August 3, 2017. An investor conference call will be held at 8:00 a.m. (ET) on Thursday, August 3... More...>>
06/22/20175:00PMBWTeleflex’s (TFX) Vascular Solutions, Inc. Issues Recall of Venture® Catheters
Vascular Solutions, Inc. voluntarily initiates a worldwide recall of Venture Catheters on April 25, 2017 Teleflex Incorporated (NYSE: TFX), announces a worldwide recall of Venture® Catheters was voluntarily initiated by its Vascular Solutions, Inc. subsidiary on April 25, 2017. Vascular Solutions, Inc. is the manufacturer... More...>>
06/02/20175:00PMBWTeleflex to Showcase Key Anesthesia Products at Euroanaesthesia 2017 (“ESA”) in Geneva
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for Critical Care, Urology and Surgery, will showcase the LMA® Protector™ and other key products in its Anesthesia portfolio, together with its innovative Vascular Access platform, at the Euroanesthesia Congress in Geneva, Switzerland on... More...>>
05/31/20176:45AMBWTeleflex to Present at the 38th Annual Goldman Sachs Global Healthcare Conference
Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 38th Annual Goldman Sachs Global Healthcare Conference at the Terranea Resort, Rancho Palos Verdes, California, on Wednesday, June 14, 2017 at 4:00 p.m. (PT). A live audio webcast of the... More...>>
05/15/20176:00PMBWTeleflex to Introduce the New Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump & the Product Portfolio from the Recently Acqu...
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, will showcase its complex PCI product portfolio recently acquired from the purchase of Vascular Solutions and the new Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump (IABP) at the EuroPCR being... More...>>
05/15/20176:30AMBWTeleflex (TFX) Announces Commencement of Phase I Clinical Study (FDP-1) of RePlas™ Freeze-Dried Plasma
The U.S. Army is sponsoring clinical trials of novel freeze-dried plasma developed by Teleflex’s Vascular Solutions division for the treatment of battlefield trauma and other emergency applications Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has... More...>>
05/08/20175:00PMBWTeleflex Quarterly Dividend – Correction of Record Date
Teleflex Incorporated (NYSE: TFX) announced that the record date for its regular quarterly dividend announced earlier today is the close of business May 18, 2017, rather than May 15, 2017. The June 15, 2017 payment date remains the same. Additional information about Teleflex can be obtained from the company’s website... More...>>
05/08/20176:45AMBWTeleflex to Present at the 2017 UBS Global Healthcare Conference
Liam Kelly, President and COO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 2017 UBS Global Healthcare Conference at the Grand Hyatt New York, New York, NY, on Monday, May 22, 2017 at 11:00 a.m. (ET). A live audio webcast of the conference presentation, along with the accompanying slide presentation... More...>>
05/08/20176:30AMBWTeleflex Announces Quarterly Dividend
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 15, 2017 to shareholders of record at the close of business on May 15, 2017. Additional information about Teleflex can be... More...>>
05/04/20176:30AMBWTeleflex Reports First Quarter 2017 Results
First Quarter Revenues of $487.9 million, up 14.8% Versus Prior Year Period; up 16.0% on Constant Currency Basis First Quarter GAAP Diluted EPS of $0.87, down 17.1% Over Prior Year Period First Quarter Adjusted Diluted EPS of $1.80, up 18.4% Versus Prior Year Period Reaffirmed 2017 Guidance Range for GAAP Revenue Growth... More...>>
05/03/20176:30AMBWTeleflex to Present at the Bank of America Merrill Lynch 2017 Health Care Conference
Liam Kelly, President and COO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Merrill Lynch 2017 Health Care Conference at the Encore at Wynn Las Vegas, Las Vegas, Nevada, on Wednesday, May 17, 2017 at 2:20 p.m. (PT). A live audio webcast of the conference presentation, along with the accompanying... More...>>
05/02/20176:45AMBWTeleflex Receives FDA 510(k) Clearance for the Arrow® AC3 OptimusTM Intra-Aortic Balloon Pump (IABP)
Advanced IABP performance with the ability to provide optimized therapy to the most challenging patient conditions, even patients with the most severe arrhythmias and heart rates as high as 200 bpm.1 Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has... More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V:us D:20170920 23:47:25